Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ipratropium

Known as: (3-endo,8-syn)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane, N-Isopropylatropine, (endo,syn)-(+-)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane 
A synthetic derivative of the alkaloid atropine with anticholinergic properties. Ipratropium antagonizes the actions of acetylcholine at… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
BACKGROUND The issue of whether regular use of an inhaled beta2-adrenergic agonist worsens airflow and clinical outcomes in… Expand
Highly Cited
2003
Highly Cited
2003
Background: A limited or absent bronchodilator response is used to classify chronic obstructive pulmonary disease (COPD) and can… Expand
Highly Cited
2002
Highly Cited
2002
Tiotropium, a novel once-daily inhaled anticholinergic, has been shown to improve lung function over a 24-h period. In order to… Expand
Highly Cited
2001
Highly Cited
2001
We compared the effectiveness of inhaled formoterol with that of ipratropium in the treatment of chronic obstructive pulmonary… Expand
Highly Cited
2000
Highly Cited
2000
The efficacy and safety of salmeterol alone was compared with the combination of salmeterol plus ipratropium and with placebo… Expand
Highly Cited
1999
Highly Cited
1999
STUDY OBJECTIVES To examine and compare the efficacy and safety of salmeterol xinafoate, a long-acting inhaled beta2-adrenergic… Expand
  • table 2
  • table 1
  • table 3
  • figure 1
  • figure 2
Highly Cited
1998
Highly Cited
1998
BACKGROUND Patients can have several illnesses concurrently, yet some of these diseases may be neglected if one problem consumes… Expand
Highly Cited
1994
Highly Cited
1994
Objective. —To determine whether a program incorporating smoking intervention and use of an inhaled bronchodilator can slow the… Expand
Highly Cited
1994
Highly Cited
1994
OBJECTIVE To determine whether a program incorporating smoking intervention and use of an inhaled bronchodilator can slow the… Expand
Highly Cited
1984
Highly Cited
1984
An autoantibody known as anti-Jo-1 antibody is found in 25% of patients with myositis. Its prevalence in patients with both… Expand